Treatment preferences in human papillomavirus-associated oropharyngeal cancer.

ABSTRACT: The population of survivors with human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC) is rising. The improved prognosis of this etiologic subset is reflected in new staging guidelines as well as ongoing deintensification trials aiming to preserve excellent survival while decreasing treatment-related toxicities. However, as staging criteria and treatment standards evolve in the era of transoral surgery and deintensification, little is known regarding the needs and treatment preferences of patients with HPV-OPSCC. Herein, the current knowledge regarding treatment preferences and priorities, quality of life and concerns among patients with HPV-OPSCC is reviewed.

SUBMITTER: Windon MJ 

PROVIDER: S-EPMC6275561 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature